相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial
G. Bellingan et al.
INTENSIVE CARE MEDICINE (2022)
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial
Giacomo Lanzoni et al.
STEM CELLS TRANSLATIONAL MEDICINE (2021)
Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential
Ellen Gorman et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2021)
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Anthony C. Gordon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series
Seyed-Mohammad Reza Hashemian et al.
STEM CELL RESEARCH & THERAPY (2021)
Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial
Xiaowei Xu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani et al.
LANCET (2021)
Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial
Ismail Hadisoebroto Dilogo et al.
STEM CELLS TRANSLATIONAL MEDICINE (2021)
Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trial
Ellen Gorman et al.
ECLINICALMEDICINE (2021)
Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial
Lei Shi et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series
Siddharth Singh et al.
BASIC RESEARCH IN CARDIOLOGY (2020)
Human Umbilical Cord-Derived Mesenchymal Stem Cells for Acute Respiratory Distress Syndrome
Hon-Kan Yip et al.
CRITICAL CARE MEDICINE (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19ARDS
Peter G. Gibson et al.
MEDICAL JOURNAL OF AUSTRALIA (2020)
Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial
Ellen Gorman et al.
TRIALS (2020)
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
Derek C. Angus et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID-19 pneumonia: A pilot study
Ying Feng et al.
CELL PROLIFERATION (2020)
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial
Fanping Meng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey
Susan J. Tzotzos et al.
CRITICAL CARE (2020)
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study
Fermin Sanchez-Guijo et al.
ECLINICALMEDICINE (2020)
Therapeutic Implications of Human Umbilical Cord Mesenchymal Stromal Cells in Attenuating Influenza A( H5N1) Virus-Associated Acute Lung Injury
Hayley Loy et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Emerging drugs for treating the acute respiratory distress syndrome
Timothy D. Shaw et al.
EXPERT OPINION ON EMERGING DRUGS (2019)
First decade of clinical trials and published studies with mesenchymal stromal cells from umbilical cord tissue
Pedro S. Couto et al.
REGENERATIVE MEDICINE (2019)
Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at US academic centers
Donald G. Phinney et al.
CYTOTHERAPY (2019)
A Comparison of Phenotypic and Functional Properties of Mesenchymal Stromal Cells and Multipotent Adult Progenitor Cells
Reenam S. Khan et al.
FRONTIERS IN IMMUNOLOGY (2019)
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial
Michael A. Matthay et al.
LANCET RESPIRATORY MEDICINE (2019)
Guidelines on the management of acute respiratory distress syndrome
Mark J. D. Griffiths et al.
BMJ OPEN RESPIRATORY RESEARCH (2019)
Psychiatric symptoms after acute respiratory distress syndrome: a 5-year longitudinal study
O. Joseph Bienvenu et al.
INTENSIVE CARE MEDICINE (2018)
Syndecan-2-positive, Bone Marrow-derived Human Mesenchymal Stromal Cells Attenuate Bacterial-induced Acute Lung Injury and Enhance Resolution of Ventilator-induced Lung Injury in Rats
Claire Masterson et al.
ANESTHESIOLOGY (2018)
Transcriptomic analysis of lung tissues after hUC-MSCs and FTY720 treatment of lipopolysaccharide-induced acute lung injury in mouse models
Zihao Huang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Isolation, cultivation, and characterization of human mesenchymal stem cells
Dolly Mushahary et al.
CYTOMETRY PART A (2018)
Simvastatin for patients with acute respiratory distress syndrome: long-term outcomes and cost-effectiveness from a randomised controlled trial
A. Agus et al.
CRITICAL CARE (2017)
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries
Giacomo Bellani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Acute respiratory distress syndrome
Rob Mac Sweeney et al.
LANCET (2016)
Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo
Michael C. W. Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review
Lauralyn A. McIntyre et al.
PLOS ONE (2016)
Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat
James Devaney et al.
THORAX (2015)
Good practice principles for sharing individual participant data from publicly funded clinical trials
Catrin Tudur Smith et al.
TRIALS (2015)
Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial
Jennifer G. Wilson et al.
LANCET RESPIRATORY MEDICINE (2015)
Early phase clinical trials to identify optimal dosing and safety
Natalie Cook et al.
MOLECULAR ONCOLOGY (2015)
Good practice principles for sharing individual participant data from publicly funded clinical trials
Catrin Tudur Smith et al.
TRIALS (2015)
MSC-Based Product Characterization for Clinical Trials: An FDA Perspective
Michael Mendicino et al.
CELL STEM CELL (2014)
Simvastatin in the Acute Respiratory Distress Syndrome
Daniel F. McAuley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study
Guoping Zheng et al.
RESPIRATORY RESEARCH (2014)
Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes
Anna Krasnodembskaya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)
Acute Respiratory Distress Syndrome The Berlin Definition
V. Marco Ranieri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
A Randomized Clinical Trial of Hydroxymethylglutaryl-Coenzyme A Reductase Inhibition for Acute Lung Injury (The HARP Study)
Thelma R. Craig et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Functional Disability 5 Years after Acute Respiratory Distress Syndrome
Margaret S. Herridge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Kenneth F. Schulz et al.
BMC MEDICINE (2010)
Simvastatin Decreases Lipopolysaccharide-induced Pulmonary Inflammation in Healthy Volunteers
Murali Shyamsundar et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Predictors of mortality in acute lung injury during the era of lung protective ventilation
E. Seeley et al.
THORAX (2008)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
分享论文
